224 related articles for article (PubMed ID: 24907633)
1. Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.
Wen J; Yang H; Liu MZ; Luo KJ; Liu H; Hu Y; Zhang X; Lai RC; Lin T; Wang HY; Fu JH
Ann Oncol; 2014 Sep; 25(9):1769-1774. PubMed ID: 24907633
[TBL] [Abstract][Full Text] [Related]
2. MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy.
Wen J; Luo K; Liu H; Liu S; Lin G; Hu Y; Zhang X; Wang G; Chen Y; Chen Z; Li Y; Lin T; Xie X; Liu M; Wang H; Yang H; Fu J
Ann Surg; 2016 May; 263(5):942-8. PubMed ID: 26445467
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study.
Liu SL; Yang H; Zhang P; Zhang L; Zhao L; Luo LL; Fu JH; Liu MZ; Xi M
Radiother Oncol; 2015 Aug; 116(2):262-8. PubMed ID: 26243678
[TBL] [Abstract][Full Text] [Related]
4. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.
Zhang JL; Wang HY; Yang Q; Lin SY; Luo GY; Zhang R; Xu GL
World J Gastroenterol; 2015 Apr; 21(14):4240-7. PubMed ID: 25892874
[TBL] [Abstract][Full Text] [Related]
5. Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation.
Hsu FM; Cheng JC; Chang YL; Lee JM; Koong AC; Chuang EY
Sci Rep; 2015 May; 5():10291. PubMed ID: 25980316
[TBL] [Abstract][Full Text] [Related]
6. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
[TBL] [Abstract][Full Text] [Related]
7. ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma.
Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Iida K; Matsubara H
Oncology; 2017; 93(3):197-203. PubMed ID: 28558382
[TBL] [Abstract][Full Text] [Related]
8. A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China.
Wu P; Zhang Z; Yuan Y; Zhang C; Zhang G; Xue L; Yang H; Wang L; Zheng X; Zhang Y; Yuan Y; Lei R; Yang Z; Zheng B; Xue Q; Sun N; He J
Int J Surg; 2022 Nov; 107():106960. PubMed ID: 36257585
[TBL] [Abstract][Full Text] [Related]
9. Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?
Liu SL; Xi M; Yang H; Yang YD; Wu YJ; Zhao L; Zhang P; Luo LL; Liu MZ
Ann Surg Oncol; 2016 Jan; 23(1):273-81. PubMed ID: 26215200
[TBL] [Abstract][Full Text] [Related]
10. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
[TBL] [Abstract][Full Text] [Related]
11. Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
Qian D; Wang Y; Zhao G; Cao F; Er P; Chen X; Cheng J; Zhang W; Li X; Zhang B; Guan Y; Zhou D; Wang J; Jiang H; Yu Z; Yuan Z; Wang P; Pang Q
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):319-328. PubMed ID: 31228553
[TBL] [Abstract][Full Text] [Related]
12. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.
Tanaka K; Otake K; Mohri Y; Ohi M; Yokoe T; Toiyama Y; Miki C; Tonouchi H; Kusunoki M
Oncol Rep; 2009 Jun; 21(6):1489-94. PubMed ID: 19424628
[TBL] [Abstract][Full Text] [Related]
14. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
15. Comparing docetaxel plus cisplatin versus fluorouracil plus cisplatin in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
Xi M; Zhang P; Zhang L; Yang YD; Liu SL; Li Y; Fu JH; Liu MZ
Jpn J Clin Oncol; 2017 Aug; 47(8):683-689. PubMed ID: 28453815
[TBL] [Abstract][Full Text] [Related]
16. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.
Gao Y; Zhu J; Zhang X; Wu Q; Jiang S; Liu Y; Hu Z; Liu B; Chen X
PLoS One; 2013; 8(1):e52589. PubMed ID: 23326344
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
Wu Y; Chen J; Zhao L; Li Q; Zhu J; Yang H; Guo S; Xi M
Cancer Res Treat; 2021 Jan; 53(1):172-183. PubMed ID: 32898941
[TBL] [Abstract][Full Text] [Related]
19. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy may not benefit esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Chen MQ; Lin QL; Chen YG; Guo JH; Xu BH; Tian Y
J Chin Med Assoc; 2017 Oct; 80(10):636-643. PubMed ID: 28716602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
